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Abstract: To evaluate the influence of zilpaterol hydrochloride (ZH) supplementation on growth performance, carcass traits, chemical
characteristics of the longissimus muscle (LM), and plasma metabolites, 16 Mahabadi castrated goats (29.93 ± 1.84 kg) were individually
fed a finishing diet without or with ZH supplementation dosed at 0.20 mg/kg BW daily. Zilpaterol was fed for 30 days with 3 days of
withdrawal before harvest. Compared with the controls, ZH supplementation decreased dry matter intake and increased total weight
gain, average daily gain, and gain for feed. Hot carcass weight, dressing percentage, and LM area were increased, but back fat thickness
and kidney-pelvic fat were reduced in the group that received ZH. Supplemental ZH did not affect the full viscera mass or stomach
complex, but it increased empty body weight (EBW) and reduced (as g/kg final EBW) the heart/lungs and kidney weights. Zilpaterol
supplementation increased LM protein and moisture and decreased LM fat. The goats fed with ZH had lower serum concentrations
of glucose, triglycerides, and cholesterol than the controls. It can be concluded that daily ZH supplementation at 0.20 mg/kg BW
increases growth performance, feed efficiency, and dressing percentage in castrated goats as a result of greater muscle accretion and
causes reduction of fat and visceral organ mass.
Key words: Carcass traits, growth performance, organ mass, β-adrenergic agonist, zilpaterol hydrochloride

1. Introduction
Zilpaterol hydrochloride (Zilmax, Intervet, South Africa)
is an orally active type 2 β-agonist approved for use in
feedlot cattle in South Africa, Mexico, and the United States
(1). In feedlot cattle, feeding zilpaterol has been shown to
improve average daily gain (ADG), feed efficiency, carcass
yield grade, hot carcass weight (HCW), and dressing
percentage in steers (2,3) and in Holstein steers (4) when
administered (dosage estimated based on average dry
matter intake (DMI) and average weight reported in those
studies) from 0.13 to 0.15 mg/kg live weight per day in
the last 20 to 42 days of the feeding period. Likewise, in
finishing lambs, zilpaterol supplementation at rates of
0.15 to 0.30 mg/kg live weight per day in the last 30 days
of the feeding period increased ADG, feed efficiency,
HCW, and dressing percentage, and it increased HCW,
dressing percentage, and longissimus muscle (LM) area
in ewe lambs (5). Compared to male lambs, the male kids
of milk/meat goat breeds generally have a lower growth
rate and lower dressing percentage (6). The latter can be
partially explained by the greater visceral mass of goats
and the fact that an appreciable proportion of energy
* Correspondence: hatefi.ali@gmail.com

expenditure can be attributed to the maintenance of
visceral organs, especially the liver and gastrointestinal
tract (7). Researchers such as Lopez-Carlos et al. found
that ZH supplementation to finishing lambs decreased the
visceral organ mass and body fat, which would partially
explain the role of zilpaterol in the enhancement of
carcass dressing percentage and energetic efficiency (5).
Therefore, ZH supplementation could be expected to
achieve a greater response in goats. Since ZH is approved
as a food additive for feedlot cattle but is currently not
approved for use in small ruminants, there is no available
information about the effect of ZH supplementation on
growth performance and carcass characteristics in male
goats. Thus, the objective of this study was to evaluate
feedlot performance, carcass traits, visceral mass, and the
chemical composition and plasma metabolites of the LM
of castrated goats fed ZH at 0.20 mg/kg of live bodyweight
during the last 30 days of the finishing period.
2. Materials and methods
This trial was conducted at the University of Tehran
Agricultural Research Center. All procedures involving
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live animals were conducted within guidelines approved
by the Institutional Animal Care and Use Committee of
the Department of Animal Science of the University in
Karaj, Iran.
2.1. Animal processing, housing and feeding
Fifty-four Mahabadi male goats (9 to 10 weeks of age)
from the University of Tehran Agricultural Research
Center were fed ad libitum twice daily with a diet for earlyweaned goats with moderate growth potential, containing
alfalfa hay, corn grain, soybean meal, and a commercial
mix of vitamins and trace elements. On a DM basis the
formulated diet provided 17.4% crude protein and 8.91
MJ NEm/kg. At 14 weeks of age the kids were castrated
(castration-band method), dewormed (Albendazole 2.5%,
Damloran Razak Pharma, Borujerd, Iran), and vaccinated
against Clostridium spp. (Enterotoxemia polyvalent, Razi
Vaccine and Serum Research Institute, Karaj, Iran). Two
weeks later, 16 kids were selected based on similar body
weight and size and were randomly assigned to individual
pens. The 16 pens used in the study were 0.96 m2 with
overhead shade, concrete floor, automatic waterers, and
0.40-m metallic feed bunks. Selected kids were fed the basal
diet for 60 days before the trial started. During the pretrial
period (60 days) and throughout the experiment (33 days),
kids were fed twice daily at 0800 and 1600 hours. Daily
feed allotments to each pen were adjusted to allow minimal
(<5%) feed refusals in the feed bunk. The amounts of feed
offered and feed refused were weighed daily. Feed bunks
were visually assessed between 0740 and 0750 hours each
morning, refusals were collected and weighed, and feed
intake was determined. Adjustments to either increase or
decrease daily feed delivery were provided at the afternoon
feeding. Feed and refusal samples were collected daily for
DM analysis, which involved oven drying the samples at
105 °C until no further weight loss occurred (8).
2.2. Experimental design and diets
The 16 Mahabadi goats (29.93 ± 1.84 kg) selected
for the study were randomly assigned to one of two
dietary treatments in a completely randomized design.
Dietary treatments consisted of the basal ﬁnishing-diet
supplemented without or with ZH dosed at 0.20 mg/
kg BW daily. The composition of the basal finishing
diet is presented in Table 1. Dietary composition was
determined by analyzing subsamples collected and
composited throughout the experiment. Samples was
subjected to the following analysis: DM (oven drying at
105 °C until no further weight loss; method 930.15 (8)),
ash (method 942.05 (8)), Kjeldahl N (method 984.13 (8)),
NDF [(corrected for NDF-ash) incorporating heat stable
α-amylase (Ankom Technology, Macedon, NY, USA) at
1 mL per 100 mL of NDF solution (Midland Scientific,
Omaha, NE, USA)], calcium (method 927.02 (8)), and
phosphorus (method 964.06 (8)). Goats that received ZH
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Table 1. Composition of experimental diets fed to goats (% of
dry matter).
Control

ZH

Alfalfa hay

25.00

25.00

Corn silage

5.00

5.00

Item
Ingredient composition (%)

Cracked corn

5.00

5.00

Barley grain

45.00

45.00

Wheat bran

5.00

5.00

Soybean meal

6.00

6.00

Canola meal

7.20

7.20

Mineral and vitamin supplement

1.80

1.80

Zilmax

-

+

Maintenance

8.91

8.91

Gain

6.06

6.06

Nutrient composition (DM basis)
Net energy (MJ/kg)

CP (%)

17.40

17.40

NDF

28.50

28.50

Ether extract (%)

2.50

2.50

Calcium (%)

0.90

0.90

Phosphorus (%)

0.42

0.42

ZH, Zilpaterol hydrochloride; mineral and vitamin supplement
contained 56% limestone, 22% NaCl, and 22% vitamin and
mineral premix containing: (mg/kg) Fe 1500, Cu 150, Mn 1000,
Zn 1500, Cu 50, and I 50; and 500,000 UI vitamin A and 250,000
UI vitamin E. Zilmax was fed to provide 0.20 mg ZH/kg of BW
daily (Zilmax, Intervet, South Africa). With the exception of net
energy, which was estimated based on tabular net energy values
for individual feed ingredients, the dietary composition was
determined by analyzing subsamples collected and composited
throughout the experiment.

were fed the β-agonist for 30 days with a 3-day withdrawal
period before harvest. To maintain the planned daily
dosage of ZH, all kids were individually weighed weekly
using electronic scales (PX 9000, Pand Ltd., Tehran, Iran)
before the morning feed (0730 hours). The daily dosage
of ZH was adjusted weekly based on the body weight and
feed intake observed in the previous week.
2.3. Growth performance data
The performance data were calculated from weights
registered before the morning feed on day 1 and day 33
of the feeding trial. Initial BW was reduced by 4% to
adjust for gastrointestinal tract contents, and all kids were
fasted for 16 h before recording the final BW. Average
daily gains were computed by subtracting the initial live
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shrunk BW from the final shrunk BW and dividing the
result by the number of days on feed. The efficiency of BW
gain was computed by dividing ADG by the daily DMI.
The corrected DMI was calculated from the as-fed intake
of feed multiplied by the DM percentage obtained from
lab analysis.
2.4. Plasma metabolite sampling and analysis
Ten milliliters of blood was collected [21G (green hub)
needle, MediPlus, UK] from the jugular vein of each
individual in heparinized tubes (Venojet, Terumo Europe,
Belgium) on days 1 and 30, 1 h before the morning meal.
Samples were immediately centrifuged for 15 min at 3000
× g at a temperature of 5 °C, and plasma was stored at –20
°C until analysis of glucose, triglycerides, and cholesterol.
Plasma metabolites were quantiﬁed by spectrophotometry
(UV-2100, Shimadzu, Kyoto, Japan) using a Diagnostic
Chemicals Ltd. kit (Pars Azmoon, Iran, for glucose,
triglycerides, and cholesterol).
2.5. Slaughter process and carcass data collection
At the end of the experiment, all kids were harvested. Kids
were transported to the Rac industrial abattoir in the city of
Karaj located 10 km from the research facilities. The time
from unloading to harvest was 6 h. At the time of harvest
gastrointestinal organs were separated and weighed, and
HCWs were recorded. After carcasses were chilled for 48
h, lambs were utilized for measurement of fat thickness,
LM area, and kidney-pelvic (KP) fat, which was removed
from the hind saddle and weighed and reported as a
percentage of carcass weight (9). The dressing percentage
was calculated by expressing HCW as a percentage of final
live BW (9). The difference between HCW and cold carcass
weight (CCW) was used to calculate the percentage of
cooling loss (9). Each carcass was split down the midline
of the vertebral column into two sides. The right side was
used for the chemical and quality analysis of the LM. After
carcass analyzing, they were immediately vacuum sealed
and carried to the laboratory under cool conditions.
2.6. Data on organ mass
All tissue masses are reported on a fresh tissue basis.
Organ mass was expressed as grams of fresh tissue per
kilogram of final empty BW. Final empty BW (EBW)
represents final BW minus the total weight of the digesta.
Full viscera mass was calculated by the summation of all
viscera components (stomach complex + small intestine
+ large intestine + liver + lungs + heart), including the
digesta. Stomach complex was calculated as the digestafree sum of weights of the rumen, reticulum, omasum, and
abomasum. To express organ mass on an EBW basis, fresh
organ mass (g) was divided by final EBW (kg).
2.7. Chemical analyses of longissimus muscle
Muscle samples were collected at 48 h postmortem from
the LM from the right side of each carcass for assessment

of muscle protein, DM, ash, and fat concentrations. The
protein, dry matter, ash, and fat content in LM samples from
all kids were determined using standard AOAC procedures
981.10, 950.46, 923.03, and 960.39, respectively (8). For
protein determination, meat protein was measured from 1
g of blended samples using the Kjeldahl procedure (Kjeltec
1030 Autoanalyzer, Foss Tecator AB, Hogans, Sweden).
The meat moisture content was measured by drying 10-g
samples at 100 °C for 20 h in a drying oven (Plus oven,
Weis-Gallenkamp, Loughborough, UK). The ash content
was determined by incineration in a muffle furnace (KR
170, Heraeus, Germany) at 550 °C for 1 h, followed by
cooling to room temperature. The LM fat was determined
in a 4-g sample using the ether extraction technique (Soxtec
system, HT, Foss Tecator 1043, Hillerød, Denmark).
2.8. Statistical analysis
Performance, carcass data, and LM chemical composition
were analyzed using the MIXED procedure of SAS (version
9.1, 2002–2003, SAS Institute Inc.) for a completely
randomized design. Treatment was considered as the fixed
effect and goat as the random effect. The effects of treatments
on visceral organ mass data (expressed as g/kg EBW) were
evaluated using a one-way classification model. Goats were
used as experimental units. In all cases, least square means
and standard error are reported, with significance at P <
0.05 and main trends at P < 0.10.
3. Results
3.1. Feeding performance
The ADG, DMI, and gain efficiency (gain for feed, G:F)
during the 60-day pretrial period were similar (P ³ 0.32)
among preassigned treatment groups, averaging 0.135 ± 0.03
kg/day, 1.29 ± 0.08 kg/day, and 0.11 ± 0.004, respectively.
The effects of zilpaterol supplementation on growth
performance are presented in Table 2. In comparison with
the controls, ZH increased total weight gain (48.1%, P <
0.01) and ADG (47.9%, P = 0.02.) and reduced DMI (10.9%,
P < 0.01); therefore, supplementation of ZH increased (P <
0.01) G:F by 65.2%.
3.2. Concentration of plasma metabolites
The effects of treatments on the plasma concentration of
glucose, triglycerides, and cholesterol measured 1 h before
feeding are shown in Table 3. On day 1, the plasma levels
of glucose, triglycerides, and cholesterol did not differ (P
> 0.18) between treatments, averaging 114.76 ± 6.0, 49.52
± 2.66, and 79.02 ± 4.85 mg/dL, respectively. However, on
day 30, the goats fed with ZH had lower (P < 0.05) serum
concentrations of glucose (12.5%), triglycerides (9.2%), and
cholesterol (11.8%) than the controls.
3.3. Carcass characteristics and LM chemical and
qualitative characteristics
The effects of treatments on carcass characteristics and
the chemical composition of the LM are presented in
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Table 2. Effect of zilpaterol hydrochloride (ZH) on feedlot performance of castrated
male goats.
Treatments1
Items

Control

ZH

SEM

Significance level

Initial2

29.84

30.00

0.71

0.87

Final3

33.77

35.82

0.54

0.02

Total weight gain (kg)

3.93

5.82

0.172

0.01

ADG (g)

119

176

15

0.02

Live BW (kg)

DMI (kg/days)

1.288

1.161

0.022

<0.01

Feed for gain

0.092

0.152

0.016

<0.01

1
Control = no zilpaterol supplementation, ZH = supplemental zilpaterol at 0.20 mg/
kg BW daily.
2
Initial weight reduced 4% to account for fill.
3
Goat kids were withdrawn 16 h before weighing and slaughtering.

Table 3. Effect of zilpaterol hydrochloride (ZH) on blood metabolites of castrated male goats.
Treatments1
Items

Control

ZH

SEM

Significance level

116.81

112.71

2.054

0.18

Serum metabolites, day 1 (mg/dL)
Glucose
Triglycerides

49.44

49.60

0.97

0.91

Cholesterol

78.97

79.07

1.77

0.97

119.43

104.55

1.72

<0.01

Serum metabolites, day 30 (mg/dL)
Glucose
Triglycerides

49.42

43.25

1.67

0.02

Cholesterol

80.85

71.31

2.36

<0.01

1
Control = no zilpaterol supplementation, ZH = supplemental zilpaterol dosed at 0.20 mg/kg
BW daily.

Table 4. Dietary ZH had no effect (P = 0.45) on cooling
loss and increased (P < 0.01) HCW by 9.9%. As a result
of an increase (P < 0.01) of the LM area by 20.4% and
a reduction (P < 0.01) of KP fat by 33.3%, dressing
percentage was increased (P < 0.01) by 3.7% in goats fed
ZH. The composition of gain was also modified by ZH.
The LM of goats fed ZH showed an increase (13.3%, P <
0.01) in protein concentration and a decrease (20.3%, P <
0.05) in fat content.
3.4. Visceral organs mass
The effects of treatments on fresh organ mass are presented
in Table 5. Supplemental ZH did not affect (P ≥ 0.14) the
full viscera or stomach complex mass. The relative value of
EBW/final BW was not affected by ZH supplementation,
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averaging 84.3%, but the EBW increased (6.1%, P = 0.03)
and the relative values (g/kg final EBW) of heart/lungs and
kidney weights decreased (P ≤ 0.04) by 10.4% and 13.9%,
respectively.
4. Discussion
4.1. Feeding performance
Mahabadi is a native goat breed from western Iran for which
there is limited information about growth performance
and carcass characteristics. Nevertheless, the rate of gain
and the carcass traits observed here for the control group
in the last 33 days are similar to those reported for intact
male Mahabadi goats finished at a similar initial BW and a
comparable diet (10). The results from the current study are
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Table 4. Effect of zilpaterol hydrochloride (ZH) on carcass characteristics and LM
chemical characteristics.
Treatments1
Items

Control

ZH

SEM

Significance level

Carcass characteristics
HCW (kg)

13.76

15.13

0.24

<0.01

Dressing percentage

40.74

42.23

0.24

<0.01

CCW (kg)

13.22

14.73

0.19

<0.01

Cooling loss (%)

2.82

2.67

0.15

0.45

LM area (cm2)

7.30

8.79

0.29

<0.01

LM chemical characteristics
Protein (%)

22.35

25.33

0.27

<0.01

Fat (%)

2.31

1.92

0.09

0.02

Ash (%)

1.41

1.57

0.08

0.09

Moisture (%)

70.62

72.74

0.32

<0.01

Fat thickness (cm)

0.75

0.62

0.03

<0.01

KPH (% of HCW2)

2.40

1.80

0.10

<0.01

Control = no zilpaterol supplementation, ZH = supplemental zilpaterol dosed at 0.20
mg/kg BW daily.
2
KPH = kidney-pelvic-heart fat, measured perpendicular to the 13th rib and 7.6 cm
ventral to the longissimus muscle.
1

Table 5. Effects of zilpaterol hydrochloride (ZH) on visceral organ mass of castrated
male goats.
Treatments1
Items
Final BW (kg)2

Control

ZH

SEM

Significance level

33.77

35.82

0.54

0.02

6.38

6.81

0.27

0.14

Empty BW (kg)

28.53

30.16

0.68

0.03

EBW (% of Final BW)

84.52

84.17

6.1

0.58

Full viscera (kg)

3

Organs (g/kg EBW)
Stomach complex4

67.62

63.89

4.12

0.38

Liver

17.04

17.18

0.43

0.76

Kidney

3.03

2.66

0.08

<0.01

Heart/Lungs

19.40

17.58

0.55

0.04

KPH fat5

28.10

21.36

1.17

<0.01

1
Control = no zilpaterol supplementation, ZH = supplemental zilpaterol dosed at
0.20 mg/kg BW daily.
2
Goat kids were withdrawn 16 h before weighing and slaughtering.
3
Full viscera = full viscera mass = (stomach complex + small intestine + large
intestine + liver + lungs + kidney + heart) including digesta.
4
Stomach complex = (rumen + reticulum + omasum + abomasum), without digesta.
5
KPH = kidney-pelvic-heart fat.
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consistent with results reported in feedlot cattle (1,2) and in
feedlot lambs (5,11) where ZH supplementation enhanced
ADG and gain efficiency. We observed that the magnitude
of the responses to ZH supplementation in terms of ADG
and gain efficiency (Table 2) in the present study were
greater (45.9% and 63.3%) than the average (32.95% and
26.17%) previously reported for ZH-fed finishing male
lambs (5,12). The effects of ZH supplementation on DMI
were less consistent. Although in the majority of studies
involving feedlot cattle (13) ZH supplementation did not
affect DMI, some reports indicated effects on DMI when
cattle were fed ZH. To the best of our knowledge (1,2),
only one study reported that zilpaterol supplementation
increased feed intake, and it was reported in lambs (11).
There is no information regarding the effect of ZH on
DMI in goats; however, as in the present study, in some
studies ZH supplementation has been reported to result
in depression of DMI in feedlot cattle. Vasconcelos et al.
(2) reported a linear decrease in the DMI of steers as the
length of ZH supplementation increased from 20 to 40
days. In contrast, Montgomery et al. (1) observed that ZH
supplementation decreased DMI by 6% in heifers but not
in steers when ZH was included in the diet for 40 days.
In a subsequent study, Montgomery et al. (1) reported a
decrease in DMI in steers when ZH was fed for 30 days.
The reasons for decreased feed intake when β-agonists are
fed has not been elucidated, but it may involve both direct
(e.g., tissue-specific) and indirect (e.g., endocrine) changes
associated with fat and muscle metabolism (14).
4.2. Concentration of plasma metabolites
According to plasma metabolite results (Table 3), the
decrease in plasma glucose in the current study may
be due to the fact that the rate of energy metabolism
increases directly in relation to muscle mass; however, in
ruminants, the effects of agonists on plasma metabolites
are inconsistent. Although data on the effects of IGF-I
on energy metabolism in ruminants are lacking, studies
in hypophysectomed rats have shown that IGF-I exerts
insulin-like effects on glucose metabolism and stimulates
glycogen synthesis in skeletal muscle (15). In accordance
with our findings, significantly higher levels of net glycogen
synthesis from glucose were observed in LM strips from
clenbuterol-fed animals than in muscle strips from control
sheep (16). In contrast, Beermann et al. (16) observed
that feeding cimaterol to growing lambs increased growth
hormone and T4 concentrations but decreased insulin and
IGF-I concentrations after 6 weeks. However, in subsequent
studies, cimaterol supplementation in lambs did not affect
IGF-I concentration but decreased T4 and markedly
decreased (50%) insulin concentrations after 3 weeks of
treatment (17). Claeys et al. (18) also reported no change
in IGF-I following chronic administration of clenbuterol
to sheep. In the same manner, no effect on blood glucose
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content was detected when terbutaline or metaproterenol,
both β-adrenergic agonists, were offered to sheep (19). In
nonruminant species, zilpaterol increased plasma glucose
levels within 72 h, but significantly decreased glucose levels
after 14 days (20). As in the present study, Galbraith et al.
(21) recorded significant reductions in plasma-free fatty
acids at day 9, but observed an increase in plasma glucose
concentration at day 49 in lambs treated with cimaterol.
Likewise, Kim et al. (22) observed significant increases in
the plasma concentrations of fatty acids and triglycerides
following supplementation with 10 ppm of cimaterol.
4.3. Carcass characteristics
The increased dressing percentage in goats fed ZH
explained 72.8% of the differential increase in gain
observed in the ZH treatment. Increased carcass weight
and dressing percentage and decreased KP fat has been
a consistent response to ZH supplementation in lambs
(6). However, in the current study, the magnitude of
these responses was two-fold greater for HCW and 22%
lower for dressing percentage, and KP fat was decreased
by 4% when compared to other studies. The potential for
increased LM area as a result of ZH supplementation in
feedlot cattle is well documented (1). However, in lambs,
the magnitude of the response has been variable, ranging
up to 30% (12). The factors that affect the magnitude
of responses to zilpaterol supplementation in terms of
growth performance and carcass characteristics in small
ruminants require further study, but may include growth
potential, age at time of feeding zilpaterol, nutritional
background, initial weight at the start of the finishing
program, number of previous days on feed in feedlot, and
final weight at time of harvest (23).
4.4. LM chemical and qualitative characteristics
About data gained for LM chemical characteristics in
Table 4, most of the β-agonists used in livestock result in
increased lipolysis, decreased lipogenesis, or increased
protein deposition by binding to the β1- or β2-adrenergic
receptors (23). The mechanism of these in vivo effects of
β-agonists is not completely understood. Protein accretion
is strongly influenced by calpastatin, which is one of
the factors causing skeletal muscle hypertrophy (24).
Some studies indicated that the activity of calpastatin,
the endogenous inhibitor of μ- and m-calpain, increases
substantially during supplementation with type 2
β-agonists (25), whereas others have suggested that
improvements in protein accretion are due to an increase
in protein. Like the present study, Baker et al. (26)
reported an increase in protein and moisture content with
a reduction in fat content in the hindquarter muscle of
lambs fed clenbuterol (a β-agonist type 2). Byrem et al.
(27) evaluated the direct action of a type 2 β-agonist on
muscle protein accretion in vivo by closed arterial infusion
of cimaterol into a single hindlimb for 21 days in growing
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steers. Net protein accretion in the treated limb was
estimated to have increased by 65% compared with that
in the contralateral, saline-infused limb. Hilton et al. (28)
reported that the estimated carcass fat from the 9th, 10th,
and 11th rib dissections was significantly less in steers,
whereas estimated carcass moisture was significantly
greater by zilpaterol supplementation. The apparent
improvement in the efficiency of energy retention per unit
DMI in finishing lambs may be due to the direct action
of the ZH on net protein retention and hence lean tissue
growth (29).
4.5. Visceral organs mass
Based on Table 5, increases in EBW with no differences
in the relative value of EBW as a percentage of final BW
were observed when sheep were fed zilpaterol. Previous
data suggest that the repartitioning effects due to type 2
β-agonists are not restricted to carcass tissues because the
amount of internal fat was significantly less in lambs fed
clenbuterol than in controls (26). Supplementation with a
type 2 β-agonist caused a decrease in visceral organ mass
(gastrointestinal tract and/or liver) in rats (30). Similarly,
a reduction in kidney (7.5%) and heart (15.4%) mass was
previously reported in lambs fed with type 2 β-agonist

cimaterol (26). ZH supplementation decreased liver
weight by 9.5% in lambs (12). However, in contrast to the
present report, there was no effect of ZH supplementation
on organ mass (expressed as percentage of BW) in steers
(3).
In summary, daily ZH supplementation of 0.20 mg/
kg BW for the last 30 days of the finishing phase improved
daily gain and feed efficiency in castrated goats. In
addition, this compound increased HCW and dressing
percentage and decreased visceral fat. The increases in
dressing percentage and LM chemical characteristics can
be direct results of greater muscle accretion, and reduction
in organ weights, and decreased visceral fat.
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